Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bio-Three in children with acute enteritis
NCT01480947Phase 4Completed
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Feb 2009
- Primary completion
- Dec 2010
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Bio-Three Hi Tablet in gastroenteritis and diarrhea (2 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoints: Quantitative Vesikari scale at 7 days and Qualitative severe diarrhea at 7 days. Started Feb 2009; status: completed.
02
Drugs
Bio-Three Hi Tablet
03
Conditions
gastroenteritisdiarrhea
Beyond the preview
Go deeper on NCT01480947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01480947.